Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

Share Price is delayed by 15 minutes
Get Live Data
17.00    0.00 (0.00%)
Bid:
16.00
Ask:
18.00
Spread: 2.00 (12.50%)
Market Cap: £12.86m
FIPP Live PriceLast checked at - London Stock Exchange

Intraday Frontier Ip Share Chart

Trading Update

22 Jul 2011 07:00

RNS Number : 8534K
Frontier IP Group plc
22 July 2011
 



 

FIPP

22 July 2011

 

 

Frontier IP Group Plc

("Frontier IP" or "the Group" or the "Company")

 

Trading Update

 

Frontier IP, which specialises in the commercialisation of university intellectual property, provides the following update on trading for the year ended 30 June 2011.

 

Frontier IP has achieved a number of significant milestones in the year. In January 2011, it completed its admission to AIM and raised £1m (gross) in an associated placing of shares and in May 2011, the Company secured its third long-term university partnership.

 

The Group's results for the year are expected to show revenue of approximately £300,000, which is more than double the previous year's result of £142,000, with the increase partly reflecting uplift in the value of the Company's portfolio holdings. The loss before tax is anticipated to be approximately £270,000, which is higher than market expectations. This is mainly due to the impact of the write down of equity and fees relating to one of the Group's portfolio companies, B1 Medical Limited, which was recently placed into administration. The Company's cash balances at 30 June 2011 stood at £582,000 and unaudited net assets per share at the year end were 41p.

 

Overall the Group's existing and pipeline portfolio is developing well and Frontier IP's new university relationship with the University of Plymouth is proceeding very positively, with an encouraging pipeline of opportunities already identified.

 

The Board expects to issue full year figures by mid-September 2011 when it looks forward to providing a further update on trading.

 

 

For further information please contact:

 

Frontier IP Group plc T: 0131 220 9491

Neil Crabb, Chairman

 

Biddicks T: 020 3178 6378

Katie Tzouliadis/ Sophie Lane

 

Arbuthnot Securities Limited T: 020 7012 2000

Tom Griffiths/Ed Groome

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUAVVRAAABUAR
Date   Source Headline
10th Nov 20207:00 amRNSAlusid - £125,000 backing from UK Future Fund
9th Nov 20206:03 pmRNSDirectors’ Dealings
6th Nov 20203:07 pmRNSHolding(s) in Company
5th Nov 20202:34 pmRNSGrant of Options
5th Nov 20207:00 amRNSAnnual results webcast hosted by LSE
5th Nov 20207:00 amRNSFinal Results
26th Oct 20207:00 amRNSPublication of newsletter
15th Oct 20207:00 amRNSTVG collaboration - Pirbright & ECO Animal Health
21st Sep 20207:00 amRNSBonduelle collaboration with Fieldwork Robotics
16th Sep 20207:00 amRNSUK Gov Future Fund invests £360k in Nandi Proteins
14th Sep 20207:00 amRNSInnovate UK backs Fieldwork Robotics with grant
9th Sep 20205:11 pmRNSHolding(s) in Company
7th Sep 20207:00 amRNSSoftware Commercialisation Director appointment
1st Sep 20207:00 amRNSElute Intelligence Patent Reader launched
24th Aug 20205:48 pmRNSHolding(s) in Company
10th Aug 20207:00 amRNSUK Gov Future Fund invests £250,000 in Pulsiv
5th Aug 20206:24 pmRNSHolding(s) in Company
4th Aug 20202:45 pmRNSHolding(s) in Company
31st Jul 20205:00 pmRNSTotal Voting Rights
30th Jul 202011:45 amRNSHolding(s) in Company
29th Jul 20202:46 pmRNSHolding(s) in Company
29th Jul 20209:11 amRNSHolding(s) in Company
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent
9th Apr 20207:00 amRNSPortfolio news: Alusid launches luxury Block range
6th Apr 202012:01 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSExscientia announces joint initiative re COVID-19
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSElute Intelligence’s AI to back COVID-19 research
26th Mar 20207:00 amRNSPortfolio news: new portfolio company AquaInSilico

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.